
Releases
Basking Biosciences Study Shows Potential to Extend Stroke Treatment Window
A new study published in Communications Biology demonstrates that the experimental drug BB-031 successfully restores blood flow in microfluidic models of acute ischemic stroke. By targeting von Willebrand Factor, the treatment remains effective against matured clots that typically resist current pharmacological standards like alteplase and tenecteplase.
























